Health-Care Giant J&J to Split Into Two Companies
Bloomberg Businessweek
00:00
Cancer After a Covet Shop
The conglomerate business model has been good for fiser. It was good for all these other companies you don't know, v artists, m big drug makers that have dig consumer divisions and a glaso as well. And the reason that they're doing it is because you make a lot more money off of drugs than you do off consumer products. Belly looked at the way that astro senika went heavily into a no do drugg research m a, particularly in the cancer field. I i hapven to be here. Im all setting them now. I have to go.
Play episode from 18:15
Transcript
